Earnest Partners LLC Charles River Laboratories International, Inc. Transaction History

Earnest Partners LLC

$22.1 Billion
Q3 2024

A detailed history of Earnest Partners LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Earnest Partners LLC holds 981,419 shares of CRL stock, worth $180 Million. This represents 0.88% of its overall portfolio holdings.

Number of Shares

981,419

Previous 1,004,486 2.3%

Holding current value

$180 Million

Previous $208 Million 6.83%

% of portfolio

0.88%

Previous 1.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$187.96 - $245.29 $4.34 Million - $5.66 Million	-23,067 Reduced 2.3%	981,419 $193 Million
Q2 2024 Aug 14, 2024	BUY	$206.39 - $268.73 $22.9 Million - $29.8 Million	110,725 Added 12.39%	1,004,486 $208 Million
Q1 2024 May 15, 2024	BUY	$203.52 - $273.43 $894,063 - $1.2 Million	4,393 Added 0.49%	893,761 $242 Million
Q4 2023 Feb 14, 2024	BUY	$164.52 - $238.84 $13.7 Million - $19.9 Million	83,485 Added 10.36%	889,368 $210 Million
Q3 2023 Nov 14, 2023	BUY	$194.44 - $217.61 $8.11 Million - $9.07 Million	41,689 Added 5.46%	805,883 $158 Million
Q2 2023 Aug 07, 2023	BUY	$183.71 - $210.25 $35.6 Million - $40.7 Million	193,802 Added 33.98%	764,194 $161 Million
Q1 2023 May 15, 2023	BUY	$191.89 - $259.92 $17.6 Million - $23.9 Million	91,806 Added 19.18%	570,392 $115 Million
Q4 2022 Feb 14, 2023	BUY	$197.11 - $250.07 $3.01 Million - $3.82 Million	15,286 Added 3.3%	478,586 $104 Million
Q3 2022 Nov 14, 2022	BUY	$182.44 - $250.54 $52.6 Million - $72.2 Million	288,052 Added 164.37%	463,300 $91.2 Million
Q2 2022 Aug 12, 2022	SELL	$204.13 - $302.4 $400,503 - $593,308	-1,962 Reduced 1.11%	175,248 $37.5 Million
Q1 2022 May 16, 2022	SELL	$255.51 - $362.11 $154,072 - $218,352	-603 Reduced 0.34%	177,210 $50.3 Million
Q4 2021 Feb 07, 2022	SELL	$351.38 - $448.68 $3.2 Million - $4.08 Million	-9,097 Reduced 4.87%	177,813 $67 Million
Q3 2021 Nov 15, 2021	SELL	$372.64 - $458.3 $8.82 Million - $10.8 Million	-23,660 Reduced 11.24%	186,910 $77.1 Million
Q2 2021 Aug 16, 2021	SELL	$294.17 - $371.65 $2.79 Million - $3.52 Million	-9,481 Reduced 4.31%	210,570 $77.9 Million
Q1 2021 May 17, 2021	SELL	$249.67 - $299.48 $11.5 Million - $13.8 Million	-46,058 Reduced 17.31%	220,051 $63.8 Million
Q4 2020 Feb 16, 2021	SELL	$222.0 - $252.62 $2.51 Million - $2.86 Million	-11,306 Reduced 4.08%	266,109 $66.5 Million
Q3 2020 Nov 16, 2020	SELL	$175.56 - $226.45 $8.93 Million - $11.5 Million	-50,840 Reduced 15.49%	277,415 $62.8 Million
Q2 2020 Aug 13, 2020	BUY	$118.84 - $189.72 $60,370 - $96,377	508 Added 0.15%	328,255 $57.2 Million
Q1 2020 May 14, 2020	BUY	$98.9 - $178.34 $5.4 Million - $9.73 Million	54,577 Added 19.98%	327,747 $41.4 Million
Q4 2019 Feb 07, 2020	BUY	$126.05 - $152.76 $4.05 Million - $4.91 Million	32,138 Added 13.33%	273,170 $41.7 Million
Q3 2019 Nov 14, 2019	BUY	$125.07 - $143.67 $38,021 - $43,675	304 Added 0.13%	241,032 $31.9 Million
Q2 2019 Aug 13, 2019	SELL	$123.4 - $148.55 $14,067 - $16,934	-114 Reduced 0.05%	240,728 $34.2 Million
Q1 2019 May 15, 2019	BUY	$104.82 - $146.73 $69,914 - $97,868	667 Added 0.28%	240,842 $35 Million
Q4 2018 Feb 14, 2019	SELL	$105.09 - $137.23 $133,779 - $174,693	-1,273 Reduced 0.53%	240,175 $27.2 Million
Q3 2018 Nov 14, 2018	SELL	$112.11 - $134.54 $615,371 - $738,490	-5,489 Reduced 2.22%	241,448 $32.5 Million
Q2 2018 Aug 13, 2018	SELL	$102.37 - $117.25 $384,092 - $439,922	-3,752 Reduced 1.5%	246,937 $27.7 Million
Q1 2018 May 15, 2018	BUY	$98.19 - $115.2 $796,713 - $934,732	8,114 Added 3.34%	250,689 $26.8 Million
Q4 2017 Feb 14, 2018	SELL	$100.43 - $118.09 $1.98 Million - $2.32 Million	-19,687 Reduced 7.51%	242,575 $26.6 Million
Q3 2017 Nov 14, 2017	BUY	$96.72 - $109.26 $2 Million - $2.26 Million	20,683 Added 8.56%	262,262 $28.3 Million
Q2 2017 Aug 14, 2017	BUY	N/A	241,579	241,579 $24.4 Million

Others Institutions Holding CRL

# of Institutions

695

Shares Held

52.2M

Call Options Held

259K

Put Options Held

463K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.33B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Earnest Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Earnest Partners LLC with notifications on news.

Account

Earnest Partners LLC Charles River Laboratories International, Inc. Transaction History